A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma

被引：0
|
作者：
Satoshi Murahashi
Daisuke Takahari
Takeru Wakatsuki
Naoki Fukuda
Takashi Ichimura
Mariko Ogura
Masato Ozaka
Eiji Shinozaki
Izuma Nakayama
Tomohiro Matsushima
Hiroki Osumi
Keisho Chin
Kensei Yamaguchi
机构：
[1] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Ramucirumab; Monotherapy; Gastric Cancer; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：92 / 97
页数：5
相关论文
共 50 条
  • [21] RETRACTED: S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil (Retracted Article)
    Lv, Fangfang
    Liu, Xin
    Wang, Biyun
    Guo, Haiyi
    Li, Jin
    Shen, Lin
    Jin, Maolin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4274 - 4279
  • [22] Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Buyukkaramikli, Nasuh C.
    Blommestein, Hedwig M.
    Riemsma, Rob
    Armstrong, Nigel
    Clay, Fiona J.
    Ross, Janine
    Worthy, Gill
    Severens, Johan
    Kleijnen, Jos
    Al, Maiwenn J.
    PHARMACOECONOMICS, 2017, 35 (12) : 1211 - 1221
  • [23] Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
    Naoki Takahashi
    Hiroki Hara
    Kengo Nagashima
    Kenro Hirata
    Toshiki Masuishi
    Toshihiko Matsumoto
    Hisato Kawakami
    Kentaro Yamazaki
    Shuichi Hironaka
    Narikazu Boku
    Kei Muro
    BMC Cancer, 23 (1)
  • [24] Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
    Takahashi, Naoki
    Hara, Hiroki
    Nagashima, Kengo
    Hirata, Kenro
    Masuishi, Toshiki
    Matsumoto, Toshihiko
    Kawakami, Hisato
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Boku, Narikazu
    Muro, Kei
    BMC CANCER, 2023, 23 (01)
  • [25] Efficacy and Safety of S-1 Monotherapy in Patients with Advanced Biliary Tract Adenocarcinoma Retrospective Analysis of 162 Patients
    Park, Inkeun
    Lee, Jae-Lyun
    Ryu, Min-Hee
    Kim, Tae-Won
    Chang, Heung Moon
    Lee, Sung Sook
    Sohn, Byeong Seok
    Kim, Eun Kyoung
    Park, Do Hyun
    Lee, Sang Soo
    Suh, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Lee, Jungshin
    ONCOLOGY, 2009, 76 (02) : 126 - 132
  • [26] A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer
    Sym, Sun Jin
    Chang, Heung Moon
    Kang, Hye Jin
    Lee, Sung Sook
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Kim, Tae-Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 63 (01) : 1 - 8
  • [27] Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer
    Roviello, Giandomenico
    Conca, Raffaele
    D'Angelo, Alberto
    Multari, Andrea Giovanni
    Paganini, Giovanni
    Chiriaco, Giorgio
    Petrioli, Roberto
    Corona, Silvia Paola
    Rosellini, Pietro
    Aieta, Michele
    ANTI-CANCER DRUGS, 2020, 31 (06) : 632 - 636
  • [28] A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer
    Sun Jin Sym
    Heung Moon Chang
    Hye Jin Kang
    Sung Sook Lee
    Min-Hee Ryu
    Jae-Lyun Lee
    Tae-Won Kim
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 63 : 1 - 8
  • [29] A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination With Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung Cancer
    Hamai, Kosuke
    Katsura, Ryo
    Miyake, Shinya
    Fujita, Suguru
    Tada, Shinpei
    Hirakawa, Tetsu
    Ueno, Sayaka
    Tanimoto, Takuya
    Ishikawa, Nobuhisa
    CANCER CONTROL, 2024, 31
  • [30] Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel
    Roviello, Giandomenico
    Corona, Silvia P.
    Multari, Andrea G.
    Petrioli, Roberto
    Rosellini, Pietro
    Aieta, Michele
    ANTI-CANCER DRUGS, 2019, 30 (07) : 745 - 748
12345